Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Abgenix, Inc., Fremont, CA, United States
Search 27 grants from Anne Messer
Search grants from Abgenix, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptors 2 & 3 (mGlu2/3) for the Treatment of Depression
Millersville University NIOSH Training Program Grant
7-2588 Imc
Group II mGluR antagonists and negative modulators in depression
Combinatorial and Algorithmic Aspects of Network Coding
Recently added grants:
Targeting cellular senescence with senolytics to improve skeletal health in older humans
The Chemistry and Biology of Galactofuranose-Containing Glycans
Diversity of TFH cells and DSA generation after kidney transplantation
Storage and recall of human B cell memory of influenza over tissues and time
Carbohydrate Public Good Interactions in Healthy and Dysbiotic Bacteroidales Communities
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
7R42NS038002-03
Application #
6351866
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2003-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$250,000
Indirect Cost
Institution
Name
Abgenix, Inc.
Department
Type
DUNS #
City
Fremont
State
CA
Country
United States
Zip Code
94555
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant